K.J. Harrison & Partners Inc Increases Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

K.J. Harrison & Partners Inc raised its position in Henry Schein, Inc. (NASDAQ:HSIC) by 61.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,000 shares of the company’s stock after acquiring an additional 11,000 shares during the quarter. K.J. Harrison & Partners Inc’s holdings in Henry Schein were worth $1,988,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Clarkston Capital Partners LLC grew its holdings in shares of Henry Schein by 5.4% in the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock valued at $101,900,000 after purchasing an additional 71,560 shares in the last quarter. Nuance Investments LLC grew its stake in shares of Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after acquiring an additional 414,748 shares in the last quarter. Olstein Capital Management L.P. grew its stake in shares of Henry Schein by 17.2% in the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after acquiring an additional 16,000 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of Henry Schein during the third quarter worth $515,000. Finally, Equitable Trust Co. acquired a new stake in shares of Henry Schein in the fourth quarter valued at $417,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently commented on HSIC shares. Wells Fargo & Company assumed coverage on Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price for the company. Jefferies Financial Group upped their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. UBS Group reduced their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and raised their price objective for the company from $69.00 to $84.00 in a report on Monday, January 6th. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Henry Schein has a consensus rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $72.54 on Thursday. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63. The firm has a market capitalization of $9.04 billion, a P/E ratio of 29.85, a P/E/G ratio of 2.13 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company’s fifty day moving average price is $74.28 and its 200 day moving average price is $72.43.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.66 EPS. As a group, sell-side analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.